What is the National Data Exchange (NDE)?

Understanding cross-state prescription data sharing for insurance claims

3 April 2026

Introduction

The National Data Exchange (NDE) is a critical advancement in Australian prescription monitoring, enabling state-based prescription monitoring systems to share data across state borders. For insurance claims management, NDE is crucial because it prevents one of the most significant loopholes in medication fraud detection: cross-border doctor and pharmacy shopping. Understanding how NDE works helps you identify claimants at risk for prescription abuse and cross-state medication diversion.

What is the National Data Exchange?

The NDE is an interoperable system that connects Australia's state-based real-time prescription monitoring (RTPM) systems, enabling prescribers and pharmacists to see a patient's controlled medication prescriptions and dispensing across multiple states simultaneously. Rather than each state maintaining separate, isolated prescription databases, the NDE creates a national view of controlled medication use.

Before NDE, a claimant could obtain oxycodone from a prescriber in NSW, benzodiazepines from a prescriber in Victoria, and additional opioids from a prescriber in Queensland, with no single pharmacist or doctor able to see the full cross-state picture. The NDE eliminates this loophole by providing practitioners a comprehensive national view.

How NDE Works

NDE operates through a federated model where individual state RTPM systems maintain their own data but share information through a secure national gateway:

NDE and Insurance Claims Management

NDE significantly impacts your insurance claims management by eliminating cross-border medication abuse loopholes:

Prevents Cross-Border Doctor Shopping

A claimant can no longer obtain duplicate controlled medications from prescribers in different states without the dispensing pharmacist seeing the full picture. NDE consolidates state data, making cross-border fraud much more difficult.

Enables Comprehensive Pharmacist Review

Clinical pharmacists conducting medication reviews for your claims can query NDE to see your claimant's complete national controlled medication history, not just the medications visible in a single state.

Supports Early Intervention

When NDE data reveals concerning cross-border prescribing patterns, you can intervene earlier through clinical review, prescriber communication, and claims management, reducing medication-related complications.

Detects Medication Diversion

Claimants who obtain medications in one state and divert them to another state become visible through NDE data showing prescriptions in multiple states without proportional dispensing records in the claimant's primary residence.

NDE Data and Your Claims Strategy

Your claims team can access NDE data in several ways:

• Through clinical pharmacist review: IMM and other clinical pharmacy services incorporate NDE data when conducting comprehensive medication reviews for your claims.
• Direct query: Some insurance companies have direct NDE access or access through their claims management software.
• Prescriber/pharmacist notification: Prescribers and pharmacists using NDE regularly may alert you to concerning patterns in your claimants' controlled medication use.

Limitations of NDE

Despite its benefits, NDE has important limitations:

• State participation: NDE effectiveness depends on all states connecting their systems. While major states are connected, full national interoperability is still evolving.
• Schedule 8 focus: NDE primarily tracks Schedule 8 (restricted) medications. Some controlled substances used for abuse (alcohol, non-scheduled prescription medications) fall outside NDE tracking.
• No international data: NDE doesn't track medications obtained internationally, though this is rare for insurance claims.
• Lag time: While NDE provides near-real-time data, there can be minor delays between dispensing and data availability.
• Requires clinical judgment: NDE shows patterns; interpreting whether patterns suggest abuse or reflect legitimate medical need requires clinical expertise.

NDE, RTPM, and Clinical Pharmacy Review

NDE, RTPM systems, and clinical pharmacy reviews form a comprehensive medication oversight framework. RTPM systems track controlled medications at the state level. NDE aggregates that data across states. Clinical pharmacy reviews interpret both RTPM and NDE data through clinical context, assessing whether patterns reflect legitimate medical need or problematic medication use, and providing specific recommendations for your claims management.

Conclusion

The National Data Exchange eliminates one of the most significant loopholes in prescription fraud detection by providing a national view of controlled medication use across state borders. For your insurance claims management, NDE data is a valuable resource for identifying high-risk medication patterns, detecting fraud, and prioritizing cases for clinical review. Combined with comprehensive medication reviews, NDE data becomes actionable intelligence supporting both claimant safety and insurance risk management.